Prolapse

Application of adjunctive perioperative vaginal estrogen failed to reduce prolapse recurrence after native tissue transvaginal prolapse repair compared with placebo, according to study results published in JAMA.

Patient-reported improvement of pelvic organ prolapse symptoms was similar for pessary vs. surgery, but ultimately did not meet the noninferiority endpoint in a 2-year randomized clinical trial, according to data published in JAMA.

Compared with pessary therapy, women who underwent surgery for symptomatic pelvic organ prolapse reported greater subjective improvement and sexual well-being, according to 1-year interim results of a randomized controlled trial.

Transvaginal mesh was noninferior to native tissue repair in women with pelvic organ prolapse at 36 months, according to a prospective, nonrandomized study published in Obstetrics & Gynecology.

Women with higher BMI, greater anatomical failure and smoking had a greater recurrence of pelvic organ prolapse — or POP — within 5 years of surgery, according to a secondary analysis of the SAVE-U trial.

KIAWAH ISLAND, S.C. — In this video from Kiawah Eye, John C. Hart Jr., MD, shares his surgical pearls on how to avoid iris prolapse and how to correct it with a technique he calls “no-touch iris repositing,” if it does occur.

Pinterest posts, or “pins,” discussing pelvic organ prolapse often lack quality and some may be subject to commercial bias, according to a study presented at the Association for Healthcare Social Media Meeting.